Results for tag: "Immune Thrombocytopenia"

Immune Thrombocytopenia (ITP) is a rare autoimmune disorder in which the body's immune system mistakenly attacks and destroys platelets, which are necessary for normal blood clotting. It is a type of thrombocytopenia, which is a decrease in the number of platelets in the blood. ITP is a common disorder in the field of Allergy and Immunology, and is usually treated with medications, such as corticosteroids, intravenous immunoglobulin, and anti-D immunoglobulin. In some cases, splenectomy may be necessary. There are several companies that specialize in the Immune Thrombocytopenia market. These include Novartis, Pfizer, GlaxoSmithKline, Sanofi, and CSL Behring. These companies develop and market treatments for ITP, as well as provide support and resources for patients and healthcare professionals. Show Less Read more